News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,496 Results
Type
Article (62680)
Company Profile (266)
Press Release (630550)
Section
Business (186672)
Career Advice (2802)
Deals (34667)
Drug Delivery (107)
Drug Development (83863)
Employer Resources (160)
FDA (16034)
Job Trends (14865)
News (328848)
Policy (31776)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (12)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (4)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2806)
Academic (2)
Accelerated approval (3)
Adcomms (26)
Allergies (83)
Alliances (46847)
ALS (88)
Alzheimer's disease (1444)
Antibody-drug conjugate (ADC) (109)
Approvals (16006)
Artificial intelligence (238)
Autoimmune disease (14)
Automation (13)
Bankruptcy (309)
Best Places to Work (11784)
BIOSECURE Act (19)
Biosimilars (99)
Biotechnology (183)
Bladder cancer (56)
Brain cancer (26)
Breast cancer (249)
Cancer (1906)
Cardiovascular disease (157)
Career advice (2361)
Career pathing (31)
CAR-T (143)
Cell therapy (409)
Cervical cancer (15)
Clinical research (67404)
Collaboration (746)
Compensation (381)
Complete response letters (28)
COVID-19 (2738)
CRISPR (40)
C-suite (204)
Cystic fibrosis (103)
Data (1809)
Decentralized trials (2)
Denatured (27)
Depression (42)
Diabetes (235)
Diagnostics (6475)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (42)
Drug discovery (114)
Drug pricing (110)
Drug shortages (24)
Duchenne muscular dystrophy (74)
Earnings (67669)
Editorial (35)
Employer branding (19)
Employer resources (141)
Events (107565)
Executive appointments (641)
FDA (17082)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (675)
Gene editing (103)
Generative AI (23)
Gene therapy (293)
GLP-1 (716)
Government (4769)
Grass and pollen (4)
Guidances (46)
Healthcare (19482)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (111)
Indications (25)
Infectious disease (2871)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (47)
Intellectual property (77)
Interviews (532)
IPO (16174)
IRA (45)
Job creations (3559)
Job search strategy (1990)
Kidney cancer (10)
Labor market (23)
Layoffs (496)
Leadership (17)
Legal (6960)
Liver cancer (72)
Lung cancer (278)
Lymphoma (123)
Machine learning (2)
Management (56)
Manufacturing (245)
MASH (59)
Medical device (13187)
Medtech (13192)
Mergers & acquisitions (18971)
Metabolic disorders (616)
Multiple sclerosis (69)
NASH (22)
Neurodegenerative disease (88)
Neuropsychiatric disorders (26)
Neuroscience (1930)
NextGen: Class of 2025 (6850)
Non-profit (4790)
Northern California (2220)
Now hiring (15)
Obesity (333)
Opinion (242)
Ovarian cancer (59)
Pain (81)
Pancreatic cancer (74)
Parkinson's disease (134)
Partnered (17)
Patents (189)
Patient recruitment (89)
Peanut (50)
People (59741)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20902)
Phase II (29593)
Phase III (22085)
Pipeline (872)
Podcasts (71)
Policy (114)
Postmarket research (2839)
Preclinical (9111)
Press Release (68)
Prostate cancer (91)
Psychedelics (32)
Radiopharmaceuticals (260)
Rare diseases (382)
Real estate (6104)
Recruiting (65)
Regulatory (22012)
Reports (31)
Research institute (2510)
Resumes & cover letters (426)
Rett syndrome (3)
RNA editing (2)
RSV (41)
Schizophrenia (67)
Series A (123)
Series B (73)
Service/supplier (9)
Sickle cell disease (54)
Southern California (1942)
Special edition (15)
Sponsored (28)
Startups (3518)
State (1)
Stomach cancer (10)
Supply chain (53)
The Weekly (43)
United States (20002)
Vaccines (714)
Venture capitalists (32)
Webinars (12)
Weight loss (230)
Women's health (31)
Worklife (16)
Date
Today (126)
Last 7 days (609)
Last 30 days (2991)
Last 365 days (34361)
2025 (6617)
2024 (35459)
2023 (39823)
2022 (50894)
2021 (55694)
2020 (54438)
2019 (47721)
2018 (36234)
2017 (32889)
2016 (32478)
2015 (37932)
2014 (30928)
2013 (26810)
2012 (28360)
2011 (28538)
2010 (27290)
Location
Africa (938)
Alabama (51)
Alaska (7)
Arizona (165)
Arkansas (12)
Asia (40434)
Australia (7193)
California (5142)
Canada (1756)
China (428)
Colorado (234)
Connecticut (259)
Delaware (121)
Europe (94225)
Florida (776)
Georgia (177)
Idaho (60)
Illinois (495)
India (21)
Indiana (282)
Iowa (5)
Japan (132)
Kansas (94)
Kentucky (24)
Louisiana (9)
Maine (59)
Maryland (807)
Massachusetts (3914)
Michigan (214)
Minnesota (336)
Mississippi (2)
Missouri (80)
Montana (31)
Nebraska (24)
Nevada (54)
New Hampshire (61)
New Jersey (1513)
New Mexico (31)
New York (1482)
North Carolina (952)
North Dakota (7)
Northern California (2220)
Ohio (183)
Oklahoma (14)
Oregon (36)
Pennsylvania (1145)
Puerto Rico (7)
Rhode Island (23)
South America (1290)
South Carolina (17)
South Dakota (1)
Southern California (1942)
Tennessee (84)
Texas (762)
Utah (156)
Virginia (127)
Washington D.C. (55)
Washington State (496)
West Virginia (3)
Wisconsin (51)
693,496 Results for "infectious diseases society of america idsa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022
Matinas BioPharma Holdings, Inc. today announced that the Infectious Diseases Society of America (IDSA), one of the four sponsoring societies for IDWeek 2022.
October 19, 2022
·
6 min read
Press Releases
Gylden’s 2025 Strategic Priorities for Advancing Innovative and Transformative Solutions for Infectious Diseases
February 25, 2025
·
7 min read
Press Releases
AGFA HealthCare Appoints Omar Sunna as Chief Customer Officer for North America
March 7, 2025
·
2 min read
BioCapital
Infectious Diseases Society of America Foundation Announces Applications for Microbial Pathogenesis in Alzheimer’s Research Grant
The Infectious Diseases Society of America Foundation is now accepting applications for the Microbial Pathogenesis in Alzheimer’s Disease Grant.
September 26, 2022
·
2 min read
Infectious disease
J&J Discontinues Phase II Dengue Study as it Retreats from Infectious Disease
J&J has recently pulled back from the infectious diseases space, including winding down R&D activity in this area in August 2023.
October 7, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Disease Progression with RADICAVA® (edaravone) in ALS
January 30, 2025
·
8 min read
Press Releases
Revive Therapeutics Announces Update on R&D Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
February 4, 2025
·
8 min read
Pharm Country
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
CorMedix Inc. today announced that two abstracts have been accepted for presentation at the Society for Healthcare Epidemiology of America (SHEA) conference being held in Houston, Texas, April 16 – 19, 2024.
April 11, 2024
·
3 min read
Press Releases
Sumitomo Pharma America Presents New Data on Nuvisertib and Enzomenib at the 2024 American Society of Hematology Annual Meeting
December 9, 2024
·
9 min read
Drug Development
Matinas BioPharma Announces Publication of Results from the Phase 2 EnACT Clinical Trial of MAT2203 in the IDSA Journal Clinical Infectious Diseases
Matinas BioPharma announces that University of Minnesota Medical School researchers published results from the Phase 2 EnACT trial evaluating MAT2203 for the treatment of cryptococcal meningitis as a Major Article and Editor’s Choice in Clinical Infectious Diseases.
August 22, 2023
·
7 min read
1 of 69,350
Next
